40780 Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel, NIBIB P41 Review 

(2018/01). 

Date: September 17–19, 2017. 

Time: 5:00 p.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard Los Angeles LA Live, 901 

West Olympic Boulevard, Los Angeles, CA 

90015. 

Contact Person: Ruixia Zhou, Ph.D., 

Scientific Review Officer, 6707 Democracy 

Boulevard, Democracy Two Building, Suite 

957, Bethesda, MD 20892, (301) 496–4773, 

zhour@mail.nih.gov. 

Dated: August 22, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–18122 Filed 8–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Council for Biomedical Imaging and 

Bioengineering. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council for Biomedical Imaging and 

Bioengineering NACBIB Council Meeting, 

September, 2017. 

Date: September 12, 2017. 

Open: 9:00 a.m. to 12:40 p.m. 

Agenda: Report from the Institute Director, 

other Institute Staff and scientific 

presentation. 

Place: The William F. Bolger Center, 

Franklin Building, Classroom 4, 9600 

Newbridge Drive, Potomac, MD 20854. 

Closed: 2:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: The William F. Bolger Center, 

Franklin Building, Classroom 4, 9600 

Newbridge Drive, Potomac, MD 20854. 

Contact Person: David T. George, Ph.D., 

Acting Associate Director, Office of Research 

Administration, National Institute of 

Biomedical Imaging and Bioengineering, 

6707 Democracy Boulevard, Room 920, 

Bethesda, MD 20892. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.nibib1.nih.gov/about/NACBIB/ 

NACBIB.htm, where an agenda and any 

additional information for the meeting 

will be posted when available. 

Dated: August 22, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–18120 Filed 8–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of an 

Interagency Pain Research Coordinating 

Committee (IPRCC) meeting. 

The meeting will feature invited 

speakers and discussions of committee 

business items including updates on the 

Federal Pain Research Strategy and new 

pain initiatives. 

The meeting will be open to the 

public and accessible by live webcast 

and conference call. 

Name of Committee: Interagency Pain 

Research Coordinating Committee. 

Type of meeting: Open Meeting. 

Date: October 23, 2017. 

Time: 8:30 a.m. to 4:30 p.m. *Eastern 

Time*—Approximate end time. 

Agenda: The meeting will feature invited 

speakers and discussions of Committee 

business items including updates on the 

Federal Pain Research Strategy and new pain 

initiatives. 

Place: National Institutes of Health, 

Building 31C, 6th Floor, Room 6, 31 Center 

Drive, Bethesda, MD 20892. 

Cost: The meeting is free and open to the 

public. 

Webcast Live: http://videocast.nih.gov/. 

Deadlines: Notification of intent to present 

oral comments: Monday, October 17, 2017, 

by 5:00 p.m. ET. Submission of written/ 

electronic statement for oral comments: 

Monday, October 17, 2017, by 5:00 p.m. ET. 

Submission of written comments: Monday, 

October 17, 2017, by 5:00 p.m. ET. 

Access: Medical Center Metro (Red Line). 

Visitor Information: http://www.nih.gov/ 

about/visitor/index.htm. 

Contact Person: Linda L. Porter, Ph.D., 

Pain Policy Advisor, Office of Pain Policy, 

Officer of the Director, National Institute of 

Neurological Disorders and Stroke, NIH, 31 

Center Drive, Room 8A31, Bethesda, MD 

20892, Phone: (301) 451–4460, Email: 

Linda.Porter@nih.gov. 

Please Note: Any member of the public 

interested in presenting oral comments to the 

Committee must notify the Contact Person 

listed on this notice by 5:00 p.m. ET on 

Monday, October 17, 2017, with their request 

to present oral comments at the meeting. 

Interested individuals and representatives of 

organizations must submit a written/ 

electronic copy of the oral statement/ 

comments including a brief description of the 

organization represented by 5:00 p.m. ET on 

Monday, October 17, 2017. 

Statements submitted will become a part of 

the public record. Only one representative of 

an organization will be allowed to present 

oral comments on behalf of that organization, 

and presentations will be limited to three to 

five minutes per speaker, depending on 

number of speakers to be accommodated 

within the allotted time. Speakers will be 

assigned a time to speak in the order of the 

date and time when their request to speak is 

received, along with the required submission 

of the written/electronic statement by the 

specified deadline. If special 

accommodations are needed, please email 

the Contact Person listed above. 

In addition, any interested person may 

submit written comments to the IPRCC prior 

to the meeting by sending the comments to 

the Contact Person listed on this notice by 

5:00 p.m. ET, Monday, October 17, 2017. The 

comments should include the name and, 

when applicable, the business or professional 

affiliation of the interested person. All 

written comments received by the deadlines 


asabaliauskas on DSKBBXCHB2PROD with NOTICES